- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Multi-Tumor Marker Quantitative Assay - 9-Item Combination for Men and 8-Item Combination for Women, Fluorescence Flow Cytometry |
| Catalog No. | TMTR-HMM-0035 |
| Description | Auxiliary diagnosis of lung cancer: Among the 7 combined tests, CYFRA21-1, NSE, CEA and CA125 are combined tests for lung cancer, which greatly enhance the auxiliary diagnostic value for lung cancer. Auxiliary diagnosis of liver cancer: In the 7-test combination, AFP is a specific indicator for primary liver cancer, CEA differentiates primary and secondary liver cancer, and free- β -HCG differentiates primary liver cancer from reproductive tumors The eight items for the auxiliary diagnosis of cervical cancer in women: The addition of SCCA is an indicator of all squamous epithelial tumors and a sensitive indicator for cervical cancer in women. It also takes into account lung squamous cell carcinoma, esophageal cancer, etc. Nine auxiliary diagnostic items for prostate cancer in men: The addition of t-PSA is a specific indicator for the prostate in men, and the ratio of f-PSA/t-PSA increases the positive rate of biopsy for gray zone prostate cancer. |
| Application | This product is used to assist in the diagnosis of high-risk malignant tumors such as liver cancer, various digestive tract tumors, ovarian cancer, breast cancer, pancreatic cancer, choriocarcinoma, and lung cancer. |
| Test Item | AFP, CA125, CYFRA21-1, CA242, CEA, free-β -HCG, NSE, Female +SCCA, Male +t-PSA, f-PSA |
| Specimen Type | Serum |
| Sample Capacity | 20-30 µL |
| Applicable Instruments | Multifunctional flow dot matrix analyzer, fully automatic flow fluorescence luminescence immunoanalyzer |
| Detection Method | Fluorescence Flow Cytometry |
| Storage | 2-8°C |
| Shelf Life | 12 months |
For research use only, not for clinical use.
|
There is no product in your cart. |